Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara M Weis

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Oncoscience|March 21, 2018
Re-thinking the preclinical development of GBM therapeuticsÉrika Cosset, Sara M Weis, David A Cheresh
Cell Stem Cell|May 6, 2014
Variety in the tumor microenvironment: integrin splicing regulates stemnessLaetitia Seguin, Sara M Weis, David A Cheresh
Cancer Cell|May 5, 2009
Agonizing integrin antagonists?Sara M Weis, Dwayne G Stupack, David A Cheresh
Cancer Metastasis Reviews|November 7, 2020
Metastasis is a highly stressful processAlejandro D Campos, Sara M Weis, David A Cheresh
Nature Medicine|April 9, 2008
Robo4 counteracts VEGF signalingLisette M Acevedo, Sara M Weis, David A Cheresh
Cell Cycle (Georgetown, Tex.)|June 7, 2014
Targeting the Achilles' heel of drug-resistant cancer stem cellsLaetitia Seguin, Maricel Gozo, Sara M Weis, et al.
Trends in Cell Biology|January 10, 2015
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistanceLaetitia Seguin, Jay S Desgrosellier, Sara M Weis, et al.
Blood|January 9, 2008
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factorLisette M Acevedo, Samuel Barillas, Sara M Weis, et al.
Cancer Research|August 23, 2015
Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescenceAleksandra Franovic, Kathryn C Elliott, Laetitia Seguin, et al.
Cancer Research|August 17, 2019
Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer ProgressionHiromi I Wettersten, Sara M Weis, Paulina Pathria, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Oncoscience|March 21, 2018
Re-thinking the preclinical development of GBM therapeuticsÉrika Cosset, Sara M Weis, David A Cheresh
Cell Stem Cell|May 6, 2014
Variety in the tumor microenvironment: integrin splicing regulates stemnessLaetitia Seguin, Sara M Weis, David A Cheresh
Cancer Cell|May 5, 2009
Agonizing integrin antagonists?Sara M Weis, Dwayne G Stupack, David A Cheresh
Cancer Metastasis Reviews|November 7, 2020
Metastasis is a highly stressful processAlejandro D Campos, Sara M Weis, David A Cheresh
Nature Medicine|April 9, 2008
Robo4 counteracts VEGF signalingLisette M Acevedo, Sara M Weis, David A Cheresh
Cell Cycle (Georgetown, Tex.)|June 7, 2014
Targeting the Achilles' heel of drug-resistant cancer stem cellsLaetitia Seguin, Maricel Gozo, Sara M Weis, et al.
Trends in Cell Biology|January 10, 2015
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistanceLaetitia Seguin, Jay S Desgrosellier, Sara M Weis, et al.
Blood|January 9, 2008
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factorLisette M Acevedo, Samuel Barillas, Sara M Weis, et al.
Cancer Research|August 23, 2015
Glioblastomas require integrin αvβ3/PAK4 signaling to escape senescenceAleksandra Franovic, Kathryn C Elliott, Laetitia Seguin, et al.
Cancer Research|August 17, 2019
Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer ProgressionHiromi I Wettersten, Sara M Weis, Paulina Pathria, et al.
Pageof 5